WALVAX BIOTECHNOLOGY
Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, is engaged in the research and development, production, and sale of bio-medicine products in the People’s Republic of China. It provides bio-medicines, such as vaccines, blood products, and others. The company offers Group A and C meningococcal polysaccharide vaccine for children and adults over the age of 2 years to prevent disease caused by the bacteria named neisseria meningitidis groups A and group C; and haemophilus infl... uenzae type b conjugate vaccine for infants from the age of 2 months to 5 years to induce immunization against infectious diseases, such as meningitis, pneumonia, septicemia, cellulitis, arthritis, and epiglottitis, etc. It also provides prefilled syringe dosage form of haemophilus influenzae type b conjugate vaccine; Group A, C meningococcal polysaccharide conjugate vaccine for infants from the age of 3 months to 5 years preventing diseases, such as cerebrospinal meningitis and septicemia; and Group ACYW135 meningococcal polysaccharide vaccine for children above 2 years old to prevent meningococcal disease caused by epidemic Neisseria meningitidis serogroups A, C, Y, and W-135. The company was founded in 2001 and is headquartered in Kunming, the People’s Republic of China.
WALVAX BIOTECHNOLOGY
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2001-01-01
Address:
Kunming, Yunnan, China
Country:
China
Website Url:
http://www.walvax.com
Total Employee:
11+
Status:
Active
Contact:
86 871 6831 2659
Total Funding:
72.8 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Tag Manager Google Analytics Content Delivery Network Global Site Tag Mobile Non Scaleable Content JsDelivr
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2012-10-26 | Hebei Daan Pharmaceutical Co., Ltd | Hebei Daan Pharmaceutical Co., Ltd acquired by Walvax Biotechnology | 529 M CNY |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-10-23 | Sirnaomics | Walvax Biotechnology investment in Series D - Sirnaomics | 105 M USD |
Official Site Inspections
http://www.walvax.com Semrush global rank: 7.07 M Semrush visits lastest month: 904
- Host name: 103.47.83.72
- IP address: 103.47.83.72
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai
More informations about "Walvax Biotechnology"
Walvax: Help Everyone Live a Healthy Life!
Founded in 2001, Walvax is mainly engaged in research and development, manufacturing and distribution of safe and efficacious vaccines. With the purpose of “Help everyone live a healthy life”, Walvax aims to be a leader in public …See details»
Walvax COVID-19 vaccine - Wikipedia
AWcorna, originally termed ARCoV and also known as the Walvax COVID-19 vaccine, is an mRNA COVID-19 vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences, and the PLA Academy of Military Science. In contrast to other mRNA COVID-19 vaccines, such as those by Pfizer-BioNTech and Moderna, this vaccine primarily targets the SARS-CoV-2 receptor-binding domain of the spike protein, rather than the entire spike protein. It is approved for Phase III trials …See details»
Walvax - LinkedIn
Walvax | 798 followers on LinkedIn. Help everyone live a healthy life! | Founded in 2001, Walvax Biotechnology Co., Ltd. (Walvax) is a leading vaccine producer, engaged in research and …See details»
CEPI partners with Shanghai Zerun Biotech to develop COVID-19 …
July 21, 2021; Oslo, Norway—CEPI, the Coalition for Epidemic Preparedness Innovations, today announced that it would partner with Shanghai Zerun Biotechnology Co., Ltd. (ZerunBio) and …See details»
CEPI, Shanghai Zerun Biotech and Walvax Biotech …
Feb 8, 2022 Founded in 2001, Walvax Biotechnology Co., Ltd. (Walvax) is a leading vaccine producer, engaged in research and development, manufacturing and distribution of safe and efficacious quality vaccines. Headquartered in …See details»
New HPV vaccine from Zerun Bio receives WHO prequalification
Walrinvax™, a bivalent human papillomavirus (HPV) vaccine, has been prequalified by the World Health Organization (WHO). Walrinvax is manufactured by Yuxi Zerun Biotechnology Co., Ltd. …See details»
A Chinese mRNA COVID vaccine is approved for the …
Sep 29, 2022 Indonesia's food and drugs agency (BPOM) greenlighted the use of Walvax Biotechnology Co Ltd's , opens new tab mRNA vaccine, which has been in development for more than two years and targets the ...See details»
Walvax Biotechnology Co.,Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Walvax Biotechnology Co.,Ltd. of Kunming, Yunnan. Get the latest business insights from Dun & …See details»
Walvax Biotechnology Co., Ltd. - Drug pipelines, Patents, Clinical ...
Explore Walvax Biotechnology Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 48 clinical trials, 3 news, and 51 literature, Disease Domain:Infectious Diseases, …See details»
Walvax Biotechnology Co Ltd | Reuters
Oct 6, 2022 Nepal has allowed China's Walvax Biotechnology (300142.SZ) to conduct phase 3 trials for the company's mRNA COVID-19 vaccine candidate in the country, China's official …See details»
Walvax Biotechnology Co., Ltd. | Insights
Nov 29, 2023 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
China's Walvax says has most participants for large mRNA COVID …
Jan 27, 2022 China's Walvax Biotechnology has recruited most of the 28,000 participants needed for a large clinical trial of its mRNA COVID-19 vaccine candidate, a senior company …See details»
Walvax Biotechnology Co., Ltd. ESG Risk Rating - Sustainalytics
Walvax Biotechnology Co Ltd is engaged in research and development, production and sales of vaccine products. Full time employees: 2,388. ESG Risk Rating. ... can be used to identify …See details»
Safety, immunogenicity, and efficacy of an mRNA COVID-19 …
RQ3013 (Walvax, China) is an mRNA vaccine designed to contain pseudouridine-modified messenger RNAs encoding the spike protein harboring a combination of mutations …See details»
What Is COVAX? And Why Is The U.S. Pouring Millions Of Vaccines …
May 19, 2021 It's a joint venture between the World Health Organization, the Center for Epidemic Preparedness and Innovation , Gavi, the Vaccine Alliance, and UNICEF, the United …See details»
China Walvax's mRNA COVID vaccine obtains first approval overseas
JAKARTA/BEIJING, Sept 29 (Reuters) - The Indonesian food and drugs agency (BPOM) said on Thursday it has approved the emergency use of an mRNA COVID-19 vaccine developed by …See details»
A potent, broadly protective vaccine against SARS-CoV-2 variants …
Nov 12, 2022 Since the first outbreak in December 2019, SARS-CoV-2 has been constantly evolving and five variants have been classified as Variant of Concern (VOC) by the World …See details»
Vaccine makers gain global edge with more R&D efforts
Nov 30, 2024 Before Walvax, US-based multinational company Pfizer was the only one in the world capable of producing PCV13 vaccines. Walvax started its PCV13 research project in …See details»
Safety, immunogenicity, and efficacy of an mRNA COVID-19 …
RQ3013 (Walvax, China) is an mRNA vaccine designed to contain pseudouridine-modified messenger RNAs encoding the spike protein harboring a combination of mutations …See details»